Assessing Novavax (NVAX) Valuation As Licensing Pivot And Key Vaccine Readout Approach Simply Wall St 23:05 Sun, 03 May
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 PR Newswire (Press Release) 21:00 Wed, 29 Apr
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know Zacks 15:12 Mon, 27 Apr
Shah Capital Blasts Novavax Strategy In New Letter To Board Scrip Pharma Intelligence 21:48 Wed, 08 Apr
Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy Benzinga 15:54 Wed, 08 Apr Article paywall